Skip to main content
Premium Trial:

Request an Annual Quote

Dan Calvo, Ricardo Macarron

Premium
Designs this week announced the appointment of Dan Calvo as president and chief executive officer. Prior to joining ADI, Calvo was president and CEO of Cellomics.
 
Calvo was previously vice president of worldwide sales and service for PerkinElmer Life and Analytical Sciences, and senior vice president of NEN Life Sciences.
 

 
The Society for Biomolecular Sciences announced this week that Ricardo Macarron, vice president of compound management of GlaxoSmithKline, assumed the office of president during its 13th Annual Conference and Exhibition in Montreal, Canada, April 15-19. 
 
Macarron joined SBS in 1999. He served as a board member of SBS from 2000 to 2002 and has been associate editor of the Journal of Biomolecular Screening since 2002. He was chair of the SBS Conference Committee from 2004 to 2005. He is also the chair of the Scientific Advisory Board of the Center for Molecular Discovery at the University of Pennsylvania.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.